STRATA Skin Sciences, Inc.

NasdaqCM:SSKN Voorraadrapport

Marktkapitalisatie: US$12.3m

STRATA Skin Sciences Beheer

Beheer criteriumcontroles 1/4

STRATA Skin Sciences' CEO is Dolev Rafaeli, appointed in Oct 2023, has a tenure of 1.08 years. total yearly compensation is $986.12K, comprised of 6.8% salary and 93.2% bonuses, including company stock and options. directly owns 3.43% of the company’s shares, worth $420.88K. The average tenure of the management team and the board of directors is 1.8 years and 6.5 years respectively.

Belangrijke informatie

Dolev Rafaeli

Algemeen directeur

US$986.1k

Totale compensatie

Percentage CEO-salaris6.8%
Dienstverband CEO1.1yrs
Eigendom CEO3.4%
Management gemiddelde ambtstermijn1.8yrs
Gemiddelde ambtstermijn bestuur6.5yrs

Recente managementupdates

Recent updates

Investors Don't See Light At End Of STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Tunnel And Push Stock Down 30%

Aug 18
Investors Don't See Light At End Of STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Tunnel And Push Stock Down 30%

Is STRATA Skin Sciences (NASDAQ:SSKN) Weighed On By Its Debt Load?

Aug 07
Is STRATA Skin Sciences (NASDAQ:SSKN) Weighed On By Its Debt Load?

STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Shares Lagging The Industry But So Is The Business

Jun 07
STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Shares Lagging The Industry But So Is The Business

Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt In A Risky Way?

Mar 19
Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt In A Risky Way?

STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Price Is Right But Growth Is Lacking After Shares Rocket 25%

Dec 31
STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Price Is Right But Growth Is Lacking After Shares Rocket 25%

Health Check: How Prudently Does STRATA Skin Sciences (NASDAQ:SSKN) Use Debt?

Nov 03
Health Check: How Prudently Does STRATA Skin Sciences (NASDAQ:SSKN) Use Debt?

We Think STRATA Skin Sciences (NASDAQ:SSKN) Has A Fair Chunk Of Debt

Jul 04
We Think STRATA Skin Sciences (NASDAQ:SSKN) Has A Fair Chunk Of Debt

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Stock Rockets 26% But Many Are Still Ignoring The Company

Apr 18
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Stock Rockets 26% But Many Are Still Ignoring The Company

Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt Sensibly?

Jan 14
Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt Sensibly?

STRATA Skin Sciences GAAP EPS of -$0.05 in-line, revenue of $9.1M beats by $0.96M

Aug 10

Strata Skin stock soars ~18% after hours on U.S. commercial launch of acne treatment

Jul 25

What Type Of Returns Would STRATA Skin Sciences'(NASDAQ:SSKN) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Mar 09
What Type Of Returns Would STRATA Skin Sciences'(NASDAQ:SSKN) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Reflecting on STRATA Skin Sciences' (NASDAQ:SSKN) Share Price Returns Over The Last Five Years

Nov 24
Reflecting on STRATA Skin Sciences' (NASDAQ:SSKN) Share Price Returns Over The Last Five Years

STRATA Skin Sciences EPS in-line, beats on revenue

Nov 10

Analyse CEO-vergoeding

Hoe is Dolev Rafaeli's beloning veranderd ten opzichte van STRATA Skin Sciences's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$8m

Mar 31 2024n/an/a

-US$11m

Dec 31 2023US$986kUS$67k

-US$11m

Sep 30 2023n/an/a

-US$7m

Jun 30 2023n/an/a

-US$7m

Mar 31 2023n/an/a

-US$6m

Dec 31 2022n/an/a

-US$6m

Sep 30 2022n/an/a

-US$6m

Jun 30 2022n/an/a

-US$6m

Mar 31 2022n/an/a

-US$3m

Dec 31 2021US$283kUS$271k

-US$3m

Sep 30 2021n/an/a

-US$2m

Jun 30 2021n/an/a

-US$3m

Mar 31 2021n/an/a

-US$6m

Dec 31 2020US$593kUS$412k

-US$4m

Sep 30 2020n/an/a

-US$4m

Jun 30 2020n/an/a

-US$4m

Mar 31 2020n/an/a

-US$3m

Dec 31 2019US$1mUS$400k

-US$4m

Sep 30 2019n/an/a

-US$3m

Jun 30 2019n/an/a

-US$3m

Mar 31 2019n/an/a

-US$3m

Dec 31 2018US$3mUS$289k

-US$4m

Compensatie versus markt: Dolev's total compensation ($USD986.12K) is above average for companies of similar size in the US market ($USD655.65K).

Compensatie versus inkomsten: Dolev's compensation has increased whilst the company is unprofitable.


CEO

Dolev Rafaeli (60 yo)

1.1yrs

Tenure

US$986,121

Compensatie

Dr. Dolev Rafaeli, Ph D., serves as Vice-Chairman, President and Chief Executive Officer at STRATA Skin Sciences, Inc. since October 30, 2023. He served as Chief Executive Officer, President and Director o...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Dolev Rafaeli
President1.1yrsUS$986.12k3.43%
$ 420.9k
Shmuel Gov
Chief Operating Officer2.6yrsUS$683.79k1.12%
$ 137.4k
John Gillings
VP of Financeless than a yeargeen gegevensgeen gegevens
Jay Sturm
General Counsel & Corporate Secretaryno datageen gegevensgeen gegevens
Michael Stewart
Independent Consultant8yrsUS$732.90kgeen gegevens

1.8yrs

Gemiddelde duur

65.5yo

Gemiddelde leeftijd

Ervaren management: SSKN's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Bestuursleden

NaamPositieTenureCompensatieEigendom
Dolev Rafaeli
President1.1yrsUS$986.12k3.43%
$ 420.9k
Daniel Lufkin
Director Emeritus14.6yrsUS$28.62kgeen gegevens
Uri Geiger
Independent Chairman6.5yrsUS$80.00kgeen gegevens
R. Anderson
Member of Scientific Advisory Board7.5yrsUS$10.25kgeen gegevens
Irit Yaniv
Independent Director1.1yrsUS$13.87kgeen gegevens
Christina Allgeier
Directorno dataUS$48.33kgeen gegevens
Shmuel Rubinstein
Independent Director6.5yrsUS$87.20k0.44%
$ 53.9k

6.5yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren bestuur: SSKN's board of directors are considered experienced (6.5 years average tenure).